T. Rowe Price Associates’s Ovid Therapeutics OVID Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-17,396
| Closed | -$6K | – | 3125 |
|
|
2025
Q1 | $6K | Hold |
17,396
| – | – | ﹤0.01% | 3030 |
|
|
2024
Q4 | $17K | Hold |
17,396
| – | – | ﹤0.01% | 2988 |
|
|
2024
Q3 | $21K | Hold |
17,396
| – | – | ﹤0.01% | 2986 |
|
|
2024
Q2 | $14K | Hold |
17,396
| – | – | ﹤0.01% | 2910 |
|
|
2024
Q1 | $54K | Buy |
17,396
+3,145
| +22% | +$9.76K | ﹤0.01% | 2864 |
|
|
2023
Q4 | $46K | Buy |
14,251
+837
| +6% | +$2.7K | ﹤0.01% | 2816 |
|
|
2023
Q3 | $52K | Buy |
13,414
+1,301
| +11% | +$5.04K | ﹤0.01% | 2769 |
|
|
2023
Q2 | $40K | Sell |
12,113
-15,387
| -56% | -$50.8K | ﹤0.01% | 2820 |
|
|
2023
Q1 | $71K | Hold |
27,500
| – | – | ﹤0.01% | 2740 |
|
|
2022
Q4 | $51K | Hold |
27,500
| – | – | ﹤0.01% | 2810 |
|
|
2022
Q3 | $51K | Sell |
27,500
-3,633
| -12% | -$6.74K | ﹤0.01% | 2834 |
|
|
2022
Q2 | $67K | Sell |
31,133
-6,828
| -18% | -$14.7K | ﹤0.01% | 2818 |
|
|
2022
Q1 | $119K | Hold |
37,961
| – | – | ﹤0.01% | 2812 |
|
|
2021
Q4 | $122K | Hold |
37,961
| – | – | ﹤0.01% | 2844 |
|
|
2021
Q3 | $128K | Hold |
37,961
| – | – | ﹤0.01% | 2793 |
|
|
2021
Q2 | $148K | Buy |
37,961
+1,213
| +3% | +$4.73K | ﹤0.01% | 2779 |
|
|
2021
Q1 | $148K | Buy |
+36,748
| New | +$148K | ﹤0.01% | 2737 |
|
|
2018
Q3 | – | Sell |
-184,811
| Closed | -$1.44M | – | 2585 |
|
|
2018
Q2 | $1.44M | Sell |
184,811
-115,669
| -38% | -$903K | ﹤0.01% | 1689 |
|
|
2018
Q1 | $2.12M | Buy |
300,480
+910
| +0.3% | +$6.43K | ﹤0.01% | 1553 |
|
|
2017
Q4 | $2.96M | Sell |
299,570
-62,070
| -17% | -$613K | ﹤0.01% | 1485 |
|
|
2017
Q3 | $2.97M | Hold |
361,640
| – | – | ﹤0.01% | 1490 |
|
|
2017
Q2 | $3.64M | Buy |
+361,640
| New | +$3.64M | ﹤0.01% | 1456 |
|